A detailed history of Pictet Asset Management Sa transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 930,914 shares of NRIX stock, worth $18.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
930,914
Previous 1,064,838 12.58%
Holding current value
$18.5 Million
Previous $9.46 Million 1.65%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$8.7 - $13.28 $1.17 Million - $1.78 Million
-133,924 Reduced 12.58%
930,914 $9.3 Million
Q1 2023

May 10, 2023

BUY
$8.56 - $13.26 $877,237 - $1.36 Million
102,481 Added 10.65%
1,064,838 $9.46 Million
Q4 2022

Feb 13, 2023

SELL
$9.86 - $14.59 $1.12 Million - $1.66 Million
-113,992 Reduced 10.59%
962,357 $10.6 Million
Q3 2022

Nov 14, 2022

SELL
$12.33 - $19.81 $4.37 Million - $7.01 Million
-354,016 Reduced 24.75%
1,076,349 $14 Million
Q2 2022

Aug 09, 2022

SELL
$7.88 - $14.82 $70,265 - $132,149
-8,917 Reduced 0.62%
1,430,365 $18.1 Million
Q1 2022

May 13, 2022

BUY
$12.94 - $29.65 $4.11 Million - $9.41 Million
317,347 Added 28.29%
1,439,282 $20.2 Million
Q4 2021

Feb 10, 2022

BUY
$26.43 - $34.5 $5.14 Million - $6.71 Million
194,385 Added 20.96%
1,121,935 $32.5 Million
Q3 2021

Nov 12, 2021

BUY
$22.71 - $36.69 $21.1 Million - $34 Million
927,550 New
927,550 $27.8 Million

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $935M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.